Cell biology in endogenous uveitis

Journal of Japanese Ophthalmological Society

Volumn 101, Issue 12, 1997, Pages 975-986

  Nakamura, Satoshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Activation induced cell death (AICD); Anti TNF alpha antibody; Apoptosis; Behcet's disease; Experimental autoimmune uveoretinitis (EAU)

Indexed keywords

CD4 ANTIGEN; CD69 ANTIGEN; FAS ANTIGEN; OKT 3; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ACTIVE IMMUNIZATION; ADULT; APOPTOSIS; ARTICLE; AUTOIMMUNITY; BEHCET DISEASE; CLINICAL ARTICLE; FEMALE; HELPER CELL; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INFLAMMATORY INFILTRATE; MALE; T LYMPHOCYTE ACTIVATION; UVEORETINITIS;

ANIMALS; APOPTOSIS; BEHCET SYNDROME; CELLS, CULTURED; MALE; RATS; RATS, INBRED LEW; T-LYMPHOCYTES; UVEITIS;

EID: 0031435994     PISSN: 00290203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. James JD : Behçet's disease. In : Fitzpatrick TB, et al (Eds) : Dermatology in General Medicine. McGraw-Hill, New York, 1239-1244, 1987.
2. Mizuki N, Ota M, Kimura M, Ohno S, Ando H, Katsuyama Y, et al : Triplet repeat polymorphism in the transmembrane region of the MICA gene : A strong association of six GCT repetitions with Behçet disease. Proc Natl Acad Sei USA 94 : 1298-1303, 1997.
3. tumor necrosis factor-alpha 96:1282 -1285, 1992.
4. Nakamura S, Sugita M, Tanaka S, Ohno S: Enhanced production of in vitro tumor necrosis factor-alpha un Behçet's disease. In : Dernouchamps JP, et al (Eds) : Recent Advances in Uveitis. Kugler Publications, Amsterdam/New York, 71-74, 1993.
5. Nakamura S, Yamakawa T, Sugita M, Kijima M, Ishioka M, Tanaka S, et al : The role of tumor necrosis factor-alpha in the induction of experimental autoimmune uveoretinitis in mice. Invest Ophthalmol Vis Sei 35 : 3884-3889, 1994.
6. Sartani G, Silver PB, Rizzo LV, Chan C-C, Wiggert B, Mastorakos G, et al : Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming. Invest Ophthalmol Vis Sei 37: 2211-2218, 1996.
7. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL : Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136: 2348-2357, 1986.
8. Keane MA, Nickell SP : Role of IL-4 and IFNgamma in modulation of immunity to Borrelia burgdorferi in mice. J Immunol 155 : 2020-2028, 1995.
9. Nakamura S, Sugita M, Matoba H, Tanaka S, Isoda F, Ohno S : Insufficient expression of Fas antigen on helper T cells in Behçet's disease. Br J Ophthalmol 80: 174-176, 1996.
10. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM : Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148 : 22072216, 1992.
11. Verities I, Haanen C, Steffens NH, Reutelingsperger C : A novel assay for apoptosis. Flow cytometric detection of phosphatidlyserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184 : 39-51, 1995.
12. Sanui H, Redmond TM, Hu LH, Kuwabara T, Margalit H, Cornette JL, et al : Synthetic peptides derived from IRBP induce EAU and EAP in Lewis rats. Curr Eye Res 7 : 727-735, 1988.
13. Gavrieli Y, Sherman Y, Ben SS : Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501, 1992.
14. Fujii N, Minagawa T, Nakane A, Kato F, Ohno S : Spontaneous production of gamma-interferon in cultures of T lymphocytes obtained from patients with Behçet's disease. J Immunol 130 : 1683-1686, 1983.
15. Suzuki Y, Hoshi K, Matsuda T, Mizushima Y : Increased peripheral blood gamma delta+ T cells and natural killer cells in Behçet's disease. J Rheumatol 19 : 588-592, 1992.
16. Onder M, Bozkurt M, Gurer MA, Gulekon A, Sezgin P, Imir T : Natural cellular cytotoxicity in Behçet's disease. J Dermatol 21 : 239-243, 1994.
17. Pender MP, Nguyen KB, McCombe PA, Kerr JF: Apoptosis in the nervous system in experimental allergic encephalomyelitis. J Neurol Sei 104: 81-87, 1991.
18. Amasaki Y, Kobayashi S, Takeda T, Ogura N, Jodo S, Nakabayashi T, et al : Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE) : A possible mechanism for lymphopenia. Clin Exp Immunol 99 : 245-250, 1995.
19. Brocke S, Gaur A, Piercy C, Gautam A, Gijbels K, Fathman CG, et al : Induction of relapsing paralysis in experimental autoimmune ence-phalomyelitis by bacterial superantigen. Nature 365 : 642-644, 1993.
20. Kerr JF, Wyllie AH, Currie AR : Apoptosis . A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26 : 239 -257, 1972.
21. Jenkinson EJ, Kingston R, Smith CA, Williams GT, Owen JJ : Anti-induced apoptosis in developing T cells : A mechanism for negative selection of the T cell receptor repertoire. Eue J Immunol 19: 2175-2177, 1989.
22. Owen SL, Yonehara S, Crump WL 3rd, Grimm EA, Crump WL: DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 140 : 197- 205, 1992.
23. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of Fas ligand, a novel member of the tumor necrosis factor family. Cell 75: 1169-1178, 1993.
24. Brunner T, Mogil RJ, LaFaee D, Yoo NJ, Mahboubi A, Echeverri F, et al : Cellautonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373: 441-444, 1995.
25. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, et al : The polypeptide encoded by the cDN A for human cell surface antigen Fas can mediate apoptosis. Cell 66 : 233 243, 1991.
26. Wang J, Stohlman SA, Dennert G : TCR crosslinking induces CTL death via internal action of TNF. J Immunol 152 : 3824-3832, 1994.
27. Mangan DF, Mergenhagen SE, Wahl SM : Apoptosis in human monocytes : Possible role in chronic inflammatory disease. J Periodontol 64 : 461-466, 1993.
28. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, et al : Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263 : 1759-1762, 1994.
29. Schmied M, Breitschopf H, Gold R, Zischler H, Rothe G, Wekerle H, et al : Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am J Pathol 143 : 446-452, 1993.
30. Tabi Z, McComebe PA, Pender MP : Antigen specific down-regulation of myelin basic proteinreactive T cells during spontaneous recovery from experimental autoimmune encephalomyelitis : Further evidence of apoptotic deletion of autoreactive T cells in the central nervous system. Int Immunol 7 : 967 -973, 1995.
31. Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis P, et al : Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor a. Arthritis Rheum 36: 1681-1690. 1993.
32. van Dullemen HM, van Deventer SJH, Hommes DW, Bijl HA, Jansen J, Tytgat GNJ, et al: Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 109: 129-135. 1995.